Organ Specific Autoimmunity | List of Frontiers open access articles

Mini Review

Published on 26 Jan 2021

Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases

in Immunological Tolerance and Regulation

Pau Serra
Pere Santamaria

Frontiers in Immunology

doi 10.3389/fimmu.2020.621774

7,712 views
24 citations

Review

Published on 15 Jul 2021

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity

in Molecular Innate Immunity

Patricia Solé
Pere Santamaria

Frontiers in Immunology

doi 10.3389/fimmu.2021.684240

9,968 views
13 citations

Mini Review

Published on 17 Dec 2013

The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity?

in Antigen Presenting Cell Biology

Javier Alonso Collado
Carolina Guitart
M. Teresa Ciudad
Iñaki Alvarez
Dolores Jaraquemada

Frontiers in Immunology

doi 10.3389/fimmu.2013.00442

11,506 views
24 citations

Original Research

Published on 19 Aug 2013

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

in Molecular Innate Immunity

Clio Mavragani
Timothy B. Niewold
Antonis Chatzigeorgiou
Stamatina Danielides
Dimitris Thomas
Kyriakos Kirou
Elli Kamper
Gregory A Kaltsas
Mary Crow

Frontiers in Immunology

doi 10.3389/fimmu.2013.00238

7,051 views
19 citations

Original Research

Published on 22 Apr 2022

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies

in Thyroid Endocrinology

Georgios Boutzios
Eleni Koukoulioti
Andreas V. Goules
Ioannis Kalliakmanis
Ilias Giovannopoulos
Panayiotis Vlachoyiannopoulos
Haralampos M. Moutsopoulos
Athanasios G. Tzioufas

Frontiers in Endocrinology

doi 10.3389/fendo.2022.860880

10,371 views
21 citations

Original Research

Published on 30 Aug 2021

Transcriptional Changes in Regulatory T Cells From Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing

in Immunological Tolerance and Regulation

Amund Holte Berger
Eirik Bratland
Thea Sjøgren
Marte Heimli
Torgeir Tyssedal
Øyvind Bruserud
Stefan Johansson
Eystein Sverre Husebye
Bergithe Eikeland Oftedal
Anette Susanne Bøe Wolff

Frontiers in Immunology

doi 10.3389/fimmu.2021.722860

5,956 views
10 citations

Review

Published on 24 Mar 2022

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies

in B Cell Biology

Inga Koneczny
John Tzartos
Marina Mané-Damas
Vuslat Yilmaz
Maartje G. Huijbers
Konstantinos Lazaridis
Romana Höftberger
Erdem Tüzün
Pilar Martinez-Martinez
Socrates Tzartos

Frontiers in Immunology

doi 10.3389/fimmu.2022.834342

17,959 views
35 citations

Articles

Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases

Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity

The Repertoires of Peptides Presented by MHC-II in the Thymus and in Peripheral Tissue: A Clue for Autoimmunity?

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies

Transcriptional Changes in Regulatory T Cells From Patients With Autoimmune Polyendocrine Syndrome Type 1 Suggest Functional Impairment of Lipid Metabolism and Gut Homing

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies